• OUR HISTORY
    OUR HISTORY
  • NEONATOLOGY
    NEONATOLOGY
  • RESPIRATORY
    RESPIRATORY
  • RARE DISEASES
    RARE DISEASES
Products

Elevating the experience of managing each patient’s condition.

 

Chiesi USA is committed to developing and commercializing products that meet the needs of healthcare providers and their patients.

We deliver our products and associated services to improve the lives of patients.
More info More info
Recent Recognitions
Top Employer United States of America 2021
The Life Science Awards
The Triangle Business Journal 2018 Best Place to Work
The Business Journal 2019 award for corporate philanthropy award winner
Working At Chiesi

At Chiesi USA, our employees come first.

 

Chiesi USA offers qualified professionals the opportunity to build a purposeful career, focused on helping others, growing professionally, achieving a fulfilling work-life balance, meeting exciting challenges and engaging in important and rewarding work.
More info News
Research & Development

Discovering and developing medical solutions to meet the unmet need
More info More info
Recent News
A new clinical framework redefines the diagnosis of COPD Exacerbations
The recommendations of an international expert panel to update the definition and severity classification of chronic obstructive pulmonary disease (COPD) exacerbations will be presented by Professor Bartolome R. Celli at the 2021...
More info More info
Our Focus

Chiesi USA is a specialty pharmaceutical company focused on developing and promoting products for the hospital, adjacent specialty and rare disease markets.

 

Celebrating over 80 years of bringing innovative products to the global healthcare marketplace, we are a proud affiliate of Chiesi Farmaceutici S.p.A.
© 2022 CHIESI USA, Inc.
175 Regency Woods Place, Suite 600, Cary, NC 27518
PP-MULTI-0024 V21.0
CHIESI ON THE WEB
chiesi-web
CHIESI USA, Inc.
follow us on:

Linkedin CHIESI USA Inc.